Published in J Virol on June 01, 1990
The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci (2001) 4.74
Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol (1991) 2.50
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol (1994) 2.29
Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A (2002) 1.92
The evolutionary dynamics of human influenza B virus. J Mol Evol (2008) 1.84
Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol (2004) 1.83
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J Virol (1995) 1.74
Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol (2011) 1.57
Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine (2008) 1.54
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J Virol (2004) 1.48
Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis (2009) 1.47
Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol (2010) 1.42
Molecular evolution of the major capsid protein VP1 of enterovirus 70. J Virol (1994) 1.29
Crystal structure of unliganded influenza B virus hemagglutinin. J Virol (2008) 1.24
A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. Vaccine (2009) 1.15
Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences. J Clin Microbiol (2000) 1.14
The contrasting phylodynamics of human influenza B viruses. Elife (2015) 1.10
Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J Virol (2005) 1.07
Emergence of an influenza B virus with antigenic change. J Clin Microbiol (2002) 1.05
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis (2014) 1.05
Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010. J Virol (2013) 1.03
Evaluation of Southern Hemisphere influenza vaccine recommendations. Vaccine (2010) 1.02
Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011-2012, Taiwan. PLoS One (2012) 0.98
Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season. J Clin Microbiol (2004) 0.98
Influenza A and B virus intertypic reassortment through compatible viral packaging signals. J Virol (2014) 0.97
Reassortment between influenza B lineages and the emergence of a coadapted PB1-PB2-HA gene complex. Mol Biol Evol (2014) 0.95
Structural basis for the divergent evolution of influenza B virus hemagglutinin. Virology (2013) 0.94
Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents. Clin Dev Immunol (2010) 0.94
Genetic analysis of influenza B viruses isolated in Uganda during the 2009-2010 seasons. Virol J (2013) 0.92
Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan. J Clin Microbiol (2005) 0.90
A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses. Influenza Other Respir Viruses (2008) 0.89
Comparison of the HA genes of type B influenza viruses in herald waves and later epidemic seasons. Epidemiol Infect (1992) 0.88
Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014. PLoS One (2015) 0.88
Diversifying selective pressure on influenza B virus hemagglutinin. J Med Virol (2009) 0.87
Domestic pigs are susceptible to infection with influenza B viruses. J Virol (2015) 0.86
Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PLoS One (2015) 0.85
Antigenic and genetic analyses of influenza type B viruses isolated in Russia, 1987-91. Epidemiol Infect (1993) 0.83
Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan. J Clin Microbiol (2006) 0.82
Fluorescent immunochromatography for rapid and sensitive typing of seasonal influenza viruses. PLoS One (2015) 0.82
The Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010-2015: The Experience of Sicily and Liguria. Int J Mol Sci (2016) 0.80
Molecular markers of influenza B lineages and clades. Viruses (2014) 0.80
Pilot Evaluation of RT-PCR/Electrospray Ionization Mass Spectrometry (PLEX-ID/Flu assay) on Influenza-Positive Specimens. Open Virol J (2012) 0.80
Reinfection with influenza B virus in children: analysis of the reinfection influenza B viruses. Epidemiol Infect (1994) 0.79
Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009. BMC Res Notes (2014) 0.78
Epidemiological, Clinical and Virological Characteristics of Influenza B Virus from Patients at the Hospital Tertiary Care Units in Bangkok during 2011-2014. PLoS One (2016) 0.77
A novel molecular test for influenza B virus detection and lineage differentiation. J Med Virol (2014) 0.75
Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan. J Clin Microbiol (2008) 0.75
Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014. PLoS One (2017) 0.75
Fifteen years of epidemiologic, virologic and syndromic Influenza surveillance: a focus on type B Virus and the effects of vaccine mismatch in Liguria region, Italy. Hum Vaccin Immunother (2016) 0.75
TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus. Sci Rep (2016) 0.75
Epidemiological and Virological Characterization of Influenza B Virus Infections. PLoS One (2016) 0.75
Reverse Genetics Approaches for the Development of Influenza Vaccines. Int J Mol Sci (2016) 0.75
New nucleotide sequence data on the EMBL file server. Nucleic Acids Res (1990) 0.75
Multiple viral introductions: molecular characterization of influenza B virus in Wenzhou, Zhejiang, China, from 2011 to 2014 based on hemagglutinin and neuraminidase genes. Arch Virol (2016) 0.75
A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol (1986) 36.06
Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature (1978) 5.43
Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology (1988) 4.03
Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature (1979) 3.91
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A (1983) 1.88
Analysis of antigenic drift in the haemagglutinin molecule of influenza B virus with monoclonal antibodies. J Gen Virol (1981) 1.85
Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies. J Virol (1984) 1.59
Sequential mutations in the NS genes of influenza virus field strains. J Virol (1983) 1.44
Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. J Gen Virol (1989) 1.43
Heterogeneity of influenza B viruses. Bull World Health Organ (1983) 1.39
Complete nucleotide sequence of the influenza B/Singapore/222/79 virus hemagglutinin gene and comparison with the B/Lee/40 hemagglutinin. Nucleic Acids Res (1983) 1.24
Antigenic structure of the hemagglutinin of influenza virus B/Hong Kong/8/73 as determined from gene sequence analysis of variants selected with monoclonal antibodies. Virology (1984) 1.17
Antigenic characteristics and genome composition of a naturally occurring recombinant influenza virus isolated from a pig in Japan. J Gen Virol (1983) 1.01
A conformational switch in syntaxin during exocytosis: role of munc18. EMBO J (1999) 5.07
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 4.71
Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem (1978) 3.97
A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron (2000) 3.93
ICRP Publication 116. Conversion coefficients for radiological protection quantities for external radiation exposures. Ann ICRP (2012) 2.59
Mechanism of action of the antifugal agent polyoxin D. J Bacteriol (1970) 2.44
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) (1976) 2.42
Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis (1980) 2.35
Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: evidence for genetic reassortment of the six internal genes. J Virol (1998) 2.11
The RIM/NIM family of neuronal C2 domain proteins. Interactions with Rab3 and a new class of Src homology 3 domain proteins. J Biol Chem (2000) 1.96
Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood. Arch Dis Child (1980) 1.86
Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur J Biochem (1978) 1.86
Metabolism of N-(2,3-dichlorophenyl)-3,4,5,6-tetrachlorophthalamic acid (techlofthalam) in paddy soil and rice. J Agric Food Chem (1982) 1.79
c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem (1997) 1.71
Dilatation of the intrahepatic bile ducts in congenital cystic dilatation of the common bile duct. Surgery (1971) 1.68
Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA. Biochem Biophys Res Commun (1994) 1.68
Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch Virol (1998) 1.65
Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol (2002) 1.64
Molecular evolution of hemagglutinin genes of H1N1 swine and human influenza A viruses. J Mol Evol (1991) 1.63
Species and strain differences in teratogenic effects of biotin deficiency in rodents. J Nutr (1989) 1.58
Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo) (1979) 1.56
Afferent and efferent connections of the oculomotor region of the fastigial nucleus in the macaque monkey. J Comp Neurol (1990) 1.52
Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta (1979) 1.47
Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem (1977) 1.47
Polyoxin D, a competitive inhibitor of UDP-N-acetylglucosamine: chitin N-acetylglucosaminyltransferase in Neurospora crassa. Biochem Biophys Res Commun (1969) 1.47
Production of tetrodotoxin and its derivatives by Pseudomonas sp. isolated from the skin of a pufferfish. Toxicon (1987) 1.47
On the signifcance of cause of death as recorded on death certificates in Hiroshima and Nagasaki, Japan. Natl Cancer Inst Monogr (1966) 1.45
Characterization of low virulent strains of highly pathogenic A/Hong Kong/156/97 (H5N1) virus in mice after passage in embryonated hens' eggs. Virology (2000) 1.42
V-ATPase of Thermus thermophilus is inactivated during ATP hydrolysis but can synthesize ATP. J Biol Chem (1998) 1.41
Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease. J Nucl Med (1997) 1.39
Heterogeneity of influenza B viruses. Bull World Health Organ (1983) 1.39
Comparing postgraduate medical education at university and non-university hospitals in Japan. Acad Med (1992) 1.39
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol (1992) 1.38
Evolutionary characterization of the six internal genes of H5N1 human influenza A virus. J Gen Virol (2000) 1.37
Antigenic comparisons of swine-influenza-like H1N1 isolates from pigs, birds and humans: an international collaborative study. Bull World Health Organ (1984) 1.36
Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment. Arch Dis Child (1981) 1.36
Genetic analysis of porcine H3N2 viruses originating in southern China. J Gen Virol (1995) 1.33
Origin and evolutionary pathways of the H1 hemagglutinin gene of avian, swine and human influenza viruses: cocirculation of two distinct lineages of swine virus. Arch Virol (1994) 1.33
Chromosomes of the zebra fish. A model for cytogenetic, embryologic, and ecologic study. J Hered (1969) 1.33
Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest (1999) 1.31
Organ doses from environmental exposures calculated using voxel phantoms of adults and children. Phys Med Biol (2012) 1.29
Isolation and characterization of cells resistant to ML236B (compactin) with increased levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem (1981) 1.27
Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Atherosclerosis (1979) 1.25
Isolation of a new avian paramyxovirus from budgerigar (Melopsittacus undulatus). J Gen Virol (1978) 1.24
Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res (1998) 1.24
Teratogenic effects of maternal biotin deficiency on mouse embryos examined at midgestation. Teratology (1990) 1.24
Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system. Jpn J Med Sci Biol (1983) 1.24
ICRP Publication 107. Nuclear decay data for dosimetric calculations. Ann ICRP (2008) 1.22
Structural features of a wheat plastome as revealed by complete sequencing of chloroplast DNA. Mol Genet Genomics (2001) 1.22
Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J Biol Chem (2000) 1.22
Pollen-based quantitative reconstructions of Holocene regional vegetation cover (plant-functional types and land-cover types) in Europe suitable for climate modelling. Glob Chang Biol (2014) 1.21
Phylogenetic analyses of the matrix and non-structural genes of equine influenza viruses. Arch Virol (1998) 1.21
Candida albicans serotype A strains grow in yeast extract-added Sabouraud liquid medium at pH 2.0, elaborating mannans without beta-1,2 linkage and phosphate group. Biochem Biophys Res Commun (1991) 1.19
Evolutionary characterization of recent human H3N2 influenza A isolates from Japan and China: novel changes in the receptor binding domain. Arch Virol (1996) 1.19
Spontaneous closure of traumatic macular hole. Retina (2001) 1.19
Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest (1995) 1.19
Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med (2000) 1.18
The possible origin H1N1 (Hsw1N1) virus in the swine population of Japan and antigenic analysis of the isolates. J Gen Virol (1982) 1.17
Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA (1994) 1.16
Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete. Br J Ophthalmol (2008) 1.15
Affinity of single- or double-stranded oligodeoxyribonucleotides containing a thymine photodimer for T4 endonuclease V. J Biol Chem (1989) 1.14
Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Lipids (1979) 1.14
Studies of a phospholipid-requiring bacterial enzyme. I. Purification and properties of uridine diphosphate galactose: lipopolysaccharide alpha-3-galactosyl transferase. Biochemistry (1969) 1.14
Japanese encephalitis vaccine. Acta Paediatr Jpn (1988) 1.13
Yolk sac tumor (endodermal sinus tumor) and alpha-fetoprotein. A report of three cases. Cancer (1973) 1.13
Non-Hodgkin's malignant lymphoma of the sinonasal tract--treatment outcome for 53 patients according to REAL classification. Auris Nasus Larynx (2001) 1.13
Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia (1999) 1.13
Spotted fever group rickettsiosis in Japan. Jpn J Med Sci Biol (1985) 1.11
Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification. J Antibiot (Tokyo) (1992) 1.11
Large outbreak of swine influenza in southern Japan caused by reassortant (H1N2) influenza viruses: its epizootic background and characterization of the causative viruses. J Gen Virol (1996) 1.10
Fundus albipunctatus associated with cone dystrophy. Br J Ophthalmol (1992) 1.09
Phylogenetic analysis of the three polymerase genes (PB1, PB2 and PA) of influenza B virus. J Gen Virol (2000) 1.09
p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res (1998) 1.08
Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology (1987) 1.08
3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors. Methods Enzymol (1981) 1.08
Genetic diversity of Argentine isolates of feline immunodeficiency virus. J Gen Virol (1996) 1.07
The sequence element of the internal ribosome entry site and a 25-kilodalton cellular protein contribute to efficient internal initiation of translation of hepatitis C virus RNA. J Virol (1997) 1.07
Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus. J Gen Virol (1991) 1.06
Genetic correlations among fatty acid compositions in different sites of fat tissues, meat production, and meat quality traits in Duroc pigs. J Anim Sci (2006) 1.06